Article
DEPRESSION AND ANXIETY SYMPTOMS FOLLOWING ELEXACAFTOR/TEZACAFTOR/IVACAFTOR IN ADULTS WITH CYSTIC FIBROSIS
2022-12-23
Abstract excerpt
<h4>Background: </h4> Elexacaftor/tezacaftor/ivacaftor (E/T/I), has broadened access to life-changing pharmacotherapy for people living with cystic fibrosis (plwCF). However, case reports suggest CFTR modulators may induce psychiatric adverse symptoms. To systematically examine this, we studied depression and anxiety symptoms before and after initiation of E/T/I. <h4>Methods: </h4>: Patient Health Questionnaire-9...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b039a4a8-9601-5b33-96ab-7d01797d992f
- DOI
- 10.22541/au.167180415.52519057/v1
